Zurich Cantonal Bank’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
WC
LPAM
ICM
CSC
HA
2L
KCM
Zurich Cantonal Bank's LFCR Position: Q4 2021 in Review
Zurich Cantonal Bank sold out of Lifecore Biomedical (LFCR) in Q4 2021, closing a stake of 4,174 shares — an estimated $38K sold.
Zurich Cantonal Bank first reported a position in LFCR in Q1 2015 and held it in 27 quarters. The position peaked at $47K in Q2 2021. 98 funds tracked by Wall St. Rank hold LFCR as of Q4 2021.
- Zurich Cantonal Bank reported no remaining Lifecore Biomedical position as of Q4 2021 after selling out during the quarter.
- Zurich Cantonal Bank sold 4,174 Lifecore Biomedical shares in Q4 2021, an estimated $38K.
- Zurich Cantonal Bank first reported a position in Lifecore Biomedical in Q1 2015 and held it in 27 quarters.
- Zurich Cantonal Bank's Lifecore Biomedical position peaked at $47K in Q2 2021.
- 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2021.
Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.